Physician profile
Saurabh Sanon
NPI 1952629255
$253,541.30
in general payments reported to CMS, 2019-2025
34 companies · $41K in 2025
The $41K reported for 2025 was more than what 96% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $20K · 2021: $9,370 · 2022: $21K · 2023: $76K · 2024: $51K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $93K · Travel and Lodging: $36K · Food and Beverage: $21K · Consulting Fee: $14K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $92,556.25 |
| Travel and Lodging | $36,283.08 |
| Food and Beverage | $20,755.36 |
| Consulting Fee | $14,125.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $116,491.31 | 2019-2025 | Mitraclip, Navitor, Triclip |
| Boston Scientific Corporation | $50,421.70 | 2019-2025 | Versacross Access Solution, Nrg Rf Transseptal Kit, Watchman Access System |
| Medtronic, INC. | $35,999.46 | 2021-2025 | Corevalve Evolut R, Protege Rx, Linq II |
| Medtronic Vascular, INC. | $15,228.54 | 2019-2020 | |
| Jenavalve Technology, INC. | $10,405.45 | 2020 | |
| Baylis Medical Company INC | $9,881.87 | 2019-2021 | |
| Inari Medical, INC. | $7,352.11 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ancora Heart, INC. | $2,378.76 | 2023-2025 | Accucinch |
| Edwards Lifesciences Corporation | $2,183.76 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| W. L. Gore & Associates, INC. | $1,353.45 | 2019-2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $230.98 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $211.23 | 2023-2025 | Impella |
| Amgen INC. | $170.31 | 2022-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $152.72 | 2019-2024 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $136.09 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire, Optowire |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saurabh Sanon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.